Related references
Note: Only part of the references are listed.Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
Baroukh M. Assael et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
Antje Schuster et al.
THORAX (2013)
Regulatory Aspects of Phase 3 Endpoints for New Inhaled Antibiotics for Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections
Alan Bruce Montgomery et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2012)
WS5.5 A randomised, open label phase 3 study to evaluate the efficacy and safety of a dry powder formulation of inhaled colistimethate sodium (Colobreathe®) versus tobramycin nebuliser solution (TNS) in cystic fibrosis subjects with chronic Pseudomonas aeruginosa lung infection
M. Goldman et al.
Journal of Cystic Fibrosis (2012)
WS5.6 A challenging double-blind, placebo-controlled study of tobramycin inhalation powder in cystic fibrosis: results of the EDIT trial
I. Galeva et al.
Journal of Cystic Fibrosis (2012)
67 Trends in health-related quality of life (HRQoL) in cystic fibrosis with tobramycin inhalation powder: the EDIT trial
A.L. Quittner et al.
Journal of Cystic Fibrosis (2012)
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
Gerd Doering et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis
Baroukh Maurice Assael
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
Michael W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
C. E. Wainwright et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Tobramycin Inhalation Powder for P. aeruginosa Infection in Cystic Fibrosis: The EVOLVE Trial
Michael W. Konstan et al.
PEDIATRIC PULMONOLOGY (2011)
Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics
Manfred Ballmann et al.
RESPIRATORY MEDICINE (2011)
Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis
Michael D. Parkins et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2011)
Cystic fibrosis and survival to 40 years: a case-control study
N. J. Simmonds et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
George Z. Retsch-Bogart et al.
CHEST (2009)
Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus
Harry Heijerman et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
Tobramycin for inhalation in cystic fibrosis: Beyond respiratory improvements
Alexander Chuchalin et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
Karen S. McCoy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience
C. R. Hansen et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Cystic fibrosis pulmonary guidelines - Chronic medications for maintenance of lung health
Patrick A. Flume et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis
David Adeboyeku et al.
JOURNAL OF CYSTIC FIBROSIS (2006)
Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease
TD Murphy et al.
PEDIATRIC PULMONOLOGY (2004)
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
ME Hodson et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis
J Emerson et al.
PEDIATRIC PULMONOLOGY (2002)
Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection
AL Quittner et al.
PEDIATRIC PULMONOLOGY (2002)
Share Paper
